Close

Jump to:

  • Navigation
  • Content
  • Footer

The Sleeping Room

Follow

Supernatural thriller film, from the producers of Panic Button.

256%
 - 
Funded
£10,000 target
£25,680 from 80 investors
More
Less

Business overview

Location Bristol, United Kingdom
Social media
Website www.moviemogulfilms.com/projects/the-...
Sectors Entertainment Non-Digital B2C
Company number 07761508
Incorporation date 5 Sep 2011
More
Less

Investment summary

Type Equity
Valuation (pre-money) £229.8K
Equity offered 10.05%
Tax relief

SEIS

  • Idea
  • Market
  • Team
  • Updates
  • Investors 80
  • Discussion
  • Documents

Idea

Introduction

- Exciting, original ghost story that delivers on chills, twists and turns with a central character that the audience really cares about.

- Well known, first rate cast.

- The film is planned to be available to UK audiences on all platforms simultaneously, enabling a choice of where and when to watch it, at an affordable price.

Intended impact

Original micro-budget feature film with huge horror genre market potential. The film has an exciting screenplay that has attracted cast of international value, delivered by a highly experienced team.

The story provides a different take on the haunted house / ghost story, by combining the angles of hidden secrets from Victorian Brighton, contained within a secret chamber of a Georgian mansion, and deeper still, within an antique Mutoscope device which offers clues to the truth behind the protagonists identity and lineage.

The Sleeping Room has the potential to make a striking and unique genre film with enough original elements to make it really stand out. The script delivers on chills and scares, whilst potentially appealing to a wider audience through its style and originality. The films universal appeal stems from the relatable and engaging story of an interesting character on a journey to discover the truth behind who she really is.

Substantial accomplishments to date

The Sleeping Room completed principal photography on December 21st 2013, shooting for 16 days on location in Brighton; directed by John Shackleton and co-produced by Gareth I Davies.

The entire shoot ran smoothly and according to schedule, thanks to the hard work, dedication and commitment of our very talented cast and crew.

The project has now entered post production, and the producers are seeking completion funding to cover costs to deliver the film in time for the Cannes Film Market in May’14.

The post house BANG in Cardiff is handling both picture and sound, for the next four months, with triple Welsh BAFTA winning editor, John Gillanders at the helm.

Film4 Frightfest festival held at the prestigious Empire Cinema in Leicester Square, London, have pledged their support for the film and there will hopefully be much press and publicity activity forthcoming in 2014.

Monetisation strategy

It is our intention to deliver an original feature film of the highest possible quality and commercial aspiration for the lowest possible price point, using only the very best available talent.

We intend to recoup production costs via international sales, and then take the film into profit from UK distribution, within the first year of release, by building an audience in advance and creating effective, targeted, cross-platform marketing campaigns, designed to ensure maximum audience reach for minimal cost.

Market price can be significantly inflated by good film festival exposure and reception. We would like to complete the film, and solicit sales companies and film festival directors for advice on the most appropriate path for our film to take, to ensure maximum ROI for all parties.

Use of proceeds

The £10,000 investment will be used for post production and delivery costs.

We are seeking to build long lasting relationships with private investors to partake in future productions once this one has proved to be a financial success.

Market

Target market

Horror genre fans and mainstream thriller audiences who enjoy a gripping story, told well through great characters and strong performances.

Characteristics of target market

The appeal for original ghost stories is a timeless one. Take for example classic titles such as THE INNOCENTS and THE SHINING. There’s the phenomena’s of THE BLAIR WITCH PROJECT and the PARANORMAL ACTIVITY franchise. Recent box office successes include THE WOMAN IN BLACK and THE CONJURING, whilst currently INSIDIOUS 2 and PARANORMAL ACTIVITY: THE MARKED ONES continue to hold their own at the box office.

Clearly audiences have an insatiable appetite to have the hairs on the back of their neck raised, and to be scared witless! These films are predominantly good stories, told well with great performances, using music and sound effects achieve their dramatic beats - and not necessarily A-list movie stars, big budgets or lavish special effects.

When a film succeeds on that rudimentary level, people tell their friends and encourage them to go and see it. We believe that THE SLEEPING ROOM holds the potential to truly connect with audiences and carry a timeless appeal.

Marketing strategy

There is nobody better placed to sell a film than its creators. By retaining UK sales and distribution rights, and raising a P&A spend through a separate crowd-funding campaign, we will have both independence and a growing audience, ahead of the films release.

We will structure a targeted marketing campaign around our world premiere, utilizing social media, PR, viral video and bespoke press events, leading towards a ‘day and date’ UK release across all platforms; cinema, pay per view TV, DVD and video on demand / digital.

We are also investigating the business case to exploit the film’s story IP rights, across key digital platforms, and capitalise on the great potential to reach an audience who sit outside mainstream media channels.

For example, a mobile app which allows the audience to probe into the backstory of the main antagonist, and the world of Mutoscope filmmaking, with the opportunity for users to create ‘What the Butler Saw’ style home movies within an app for themselves, captured on a hand held device, and the end results shared on social media networks, to ultimately increase the awareness, and discoverability of the film.

Competition strategy

THE SLEEPING ROOM is our second feature film release and so we have the benefit of experience on our side.

Every film is a unique offering to audiences and the truth is that nobody really knows what people will respond to. Traditionally the problem for low budget independent films is getting them seen. Sales companies and distributors are reluctant to gamble big money on a cinema release with an unproven product, and in most cases, nothing at all. So until a film is presented to a paying audience, how can we gauge its true potential? For an independent film to truly break out on the scale of notorious supernatural financial successes such as The Blair Witch Project and Paranormal Activity, studio backing is essential because this requires a huge P&A spend to position the film in multiplexes.

The only way to procure studio backing is by proving a phenomenal audience reaction to a film on your own, and some strong box office success. Financing our own small cinema release through crowd-funding, will provide THE SLEEPING ROOM with the opportunity to find out if the film can actually gain the necessary traction with paying audiences to break out. We believe that this film has the potential, and if successful, then it will certainly lead to an extended run and some newsworthy press.

Open an account to get access to the team members of The Sleeping Room

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for The Sleeping Room has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 20 February 2014 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £229,808

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel